Nidec Corp (NJ) 16.75 $NJ Nidec reports Q4

New Post Public Reply Private Reply Replies (0) Message Board

Apr 22, 2015 at 10:34 PM

Nidec Corp (NJ) 16.75 $NJ

Nidec reports Q4 results
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 6:11AM CDT

NJ: 16.75 (-0.59)

Nidec Announces Financial Results for Fiscal Year Ended March 31, 2015
GlobeNewswire - Wed Apr 22, 6:00AM CDT
Nidec Corporation (NYSE:NJ) today announced consolidated results under U.S. GAAP for the fiscal year ended March 31, 2015. The highlights are as follows:
NJ: 16.75 (-0.59)

Strong And Under The Radar: Nidec (NJ)
at The Street - Thu Apr 02, 8:51AM CDT
Trade-Ideas LLC identified Nidec (NJ) as a strong and under the radar candidate
NJ: 16.75 (-0.59)

Nidec Announces the Status of Own Share Repurchase
GlobeNewswire - Wed Apr 01, 1:30AM CDT
Nidec Corporation (NYSE:NJ) (the "Company"

today announced the status of the Company's own share repurchase under its ongoing repurchase plan resolved at the meeting of the Board of Directors held on January 22 , 2015, pursuant to Article 459, Paragraph 1, Item 1 of the Company Law of Japan.
NJ: 16.75 (-0.59)

Nidec Motor Corporation Files Second Patent Lawsuit against Broad Ocean Companies
Business Wire - Mon Mar 30, 8:00AM CDT
Nidec Motor Corporation ("NMC"

filed its second patent infringement action against three Broad Ocean companies (Zhongshan Broad Ocean Motor Co., Ltd., Broad Ocean Technologies, LLC, and Broad Ocean Motor LLC, collectively "Broad Ocean"

and the Broad Ocean motor distributor MARS Motors & Armatures, Inc. ("MARS"

. This second lawsuit was filed in the United States District Court for the Eastern District of Texas and alleges that certain of Broad Ocean's blower motors for use in HVAC applications, including motors manufactured for and sold by MARS under the AZURE(R) name, infringe multiple patents owned by NMC.
NJ: 16.75 (-0.59)

Nidec Announces Completion of Share Repurchase Through Off-Auction Own Share Repurchase Trading (ToSTNeT-3)
GlobeNewswire - Mon Feb 16, 7:30PM CST
Nidec Corporation (NYSE:NJ) (the "Company"

announced that, in connection with its announcement released on February 16, 2015, the Company has repurchased shares of its common stock through the Tokyo Stock Exchange Trading Network system for Off-Auction Own Share Repurchase Trading (ToSTNeT-3) today as described below:
NJ: 16.75 (-0.59)

Nidec Announces Share Repurchase Through Off-Auction Own Share Repurchase Trading (ToSTNeT-3)
GlobeNewswire - Mon Feb 16, 1:30AM CST
Nidec Corporation (NYSE:NJ) (the "Company"

announced that it has decided the specific method of own share repurchase of its common stock. A repurchase is conducted as a part of the share repurchase plan authorized at the meeting of Board of Directors held on January 22, 2015 pursuant to Article 156, Paragraph 1, and Nidec's Articles of Incorporation based on Article 459, Paragraph 1, Item 1 of the Company Law of Japan. Details of the method of repurchase are as follows:
NJ: 16.75 (-0.59)

Nidec Completes Acquisition of Geraete- und Pumpenbau GmbH Dr. Eugen Schmidt and Announces Outlines of Its New Subsidiaries
GlobeNewswire - Mon Feb 02, 5:30PM CST
Nidec Corporation (NYSE:NJ) (the "Company" or "Nidec"

today announced that it has completed the acquisition of all of the shares in Gerate- und Pumpenbau GmbH Dr. Eugen Schmidt ("GPM"

from its shareholders, through the Company's subsidiary, Nidec Motors & Actuators (Germany) GmbH ("NMA(G)"

, on February 2, 2015 (the "Transaction"

. As a result of the Transaction, GPM became a consolidated subsidiary of Nidec, as outlined below:
NJ: 16.75 (-0.59)

Nidec (NJ) Showing Signs Of Being Strong And Under The Radar
at The Street - Tue Jan 27, 8:57AM CST
Trade-Ideas LLC identified Nidec (NJ) as a strong and under the radar candidate
NJ: 16.75 (-0.59)

Nidec Announces the Status of Share Repurchases and the Conclusion of the Share Repurchase Plan
GlobeNewswire - Mon Jan 26, 12:29AM CST
Nidec Corporation (NYSE:NJ) (the "Company"

today announced the status of the Company's share repurchases under its repurchase plan in accordance with the Articles of Incorporation pursuant to Article 459, Paragraph 1, Item 1 of the Company Law of Japan.
NJ: 16.75 (-0.59)

Nidec Corporation (NJ) Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Jan 23, 9:47PM CST

NJ: 16.75 (-0.59)

Nidec EPS of ¥71.42
Seeking Alpha - at Seeking Alpha - Thu Jan 22, 4:57AM CST

NJ: 16.75 (-0.59)

Nidec Board Authorizes Share Repurchase Plan
GlobeNewswire - Thu Jan 22, 1:21AM CST
Nidec Corporation (NYSE:NJ) (the "Company"

announced today that its Board of Directors has authorized a new share repurchase plan at a meeting held on January 22, 2015, whereby the Company may repurchase up to 4 million shares in accordance with the Articles of Incorporation pursuant to Article 459, Paragraph 1, Item 1 of the Company Law of Japan.
NJ: 16.75 (-0.59)

Nidec Revises Consolidated Financial Forecast and Year-End Dividend Projection for the Year Ending March 31, 2015
GlobeNewswire - Thu Jan 22, 1:18AM CST
Nidec Corporation (NYSE:NJ) (the "Company"

today announced an upward revision to its U.S. GAAP-based consolidated full-year financial forecast and year-end dividend projection for the year ending March 31, 2015.
NJ: 16.75 (-0.59)

Nidec Announces Financial Results for Third Quarter and Nine Months Ended December 31, 2014
GlobeNewswire - Thu Jan 22, 1:09AM CST
Nidec Corporation (NYSE:NJ) today announced consolidated results under U.S. GAAP for the third quarter (October-December 2014) and nine months (April-December 2014).
NJ: 16.75 (-0.59)

Nidec to Acquire Geraete - und Pumpenbau GmbH Dr. Eugen Schmidt
GlobeNewswire - Thu Dec 11, 6:15PM CST
Nidec Corporation (NYSE:NJ) (the "Company" or "Nidec"

today announced that it has agreed to acquire 100% of the shares of Gerate- und Pumpenbau GmbH Dr. Eugen Schmidt ("GPM"

from its shareholders, through the Company's subsidiary, Nidec Motors & Actuators (Germany) GmbH ("NMA(G)"

(the "Transaction"

. For this purpose, the Company entered into a share purchase and transfer agreement (the "Share Purchase Agreement"

with each of GPM's shareholders.
NJ: 16.75 (-0.59)

Nidec to Acquire Certain Operating Assets of China Tex Mechanical & Electrical Engineering Co., Ltd.
GlobeNewswire - Thu Dec 11, 5:30PM CST
Nidec Corporation (NYSE:NJ) (the "Company" or "Nidec"

today announced that it has agreed to acquire certain operating assets of China Tex Mechanical & Electrical Engineering Co., Ltd. ("China Tex MEE"

, a China-based electric motor and drive manufacturer, through Nidec Motor (Qingdao) Co., Ltd. (NMQC) (the "Transaction"

. For this purpose, NMQC entered into a definitive agreement with China Tex MEE on November 12, 2014.
NJ: 16.75 (-0.59)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

JOYEE N01 Debuts Globally with First 2,000 Deliveries

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Viking Ventures: Impacts of VK2735 on Obesity Examined

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

CVS Study: GLP-1 Drugs Effective But Costly

By Hannah Lewis Updated Nov 15, 2026 Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

D-Wave Quantum Hit with Securities Fraud Lawsuit

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

IDEAYA's IDE101: A New Front in Cancer Battle

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

KINGRVER Boosts RV Comfort with New Water Heater Lineup

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....